Listed

NovaBridge Biosciences: Form 20-F for the period ended Dec 31, 2020

Filed with the SEC on Apr 28, 2021 and accepted by EDGAR at Apr 28, 2021, 07:47 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-01-01 to 2020-12-31$236.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development12 months2020-01-01 to 2020-12-31$150.9mus-gaap:ResearchAndDevelopmentExpense
Interest expense12 months2020-01-01 to 2020-12-31$147.0kus-gaap:InterestExpense
Income tax12 months2020-01-01 to 2020-12-31$1.9mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2020-01-01 to 2020-12-31$72.2mus-gaap:NetIncomeLoss
Diluted EPS12 months2020-01-01 to 2020-12-31$0.46us-gaap:EarningsPerShareDiluted
Basic EPS12 months2020-01-01 to 2020-12-31$0.54us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2020-01-01 to 2020-12-31157,231,652 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2020-01-01 to 2020-12-31$66.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$1.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-12-31$729.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$819.0mus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$970.7mus-gaap:Assets
Current liabilitiesAt period end2020-12-31$88.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$108.3mus-gaap:Liabilities
Shareholders' equityAt period end2020-12-31$862.4mus-gaap:StockholdersEquity
Shares outstandingAt period end2020-12-31164,888,519 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001193125-21-135440. Last ingested by Listed: Nov 6, 2026, 02:19 ET. Listed shows no prices and gives no investment advice.